Læknablaðið

Árgangur

Læknablaðið - 15.11.1988, Blaðsíða 12

Læknablaðið - 15.11.1988, Blaðsíða 12
358 LÆKNABLAÐIÐ 9. Burstein M, Scholnick HR, Morfin R. Rapid estimation for the isolation of lipoproteins from human serum by preciptitation with polyanions. J Lipid Res 1970; 11: 583-95. 10. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502. 11. Illingworth DR. Specific inhibitors of cholesterol biosynthesis and hypocholesterolemic agents in humans: Mevinolin and compactin. Pharmacological control of Hyperlipidemia. Prous Science Publishers SA 1986: 231-49. 12. Illingworth DR, Sexton GJ. Hypocholesterolemic effects of mevinolin in patients with heterozygon familial hyopercolesterolemia. J Clin Invest 1984; 74: 1972-8. 13. Havel RJ et al. Lovastatin (Mevinolin) in the treatment of heterozygons familial hypercholesterolemia. A multicenter study. Ann Int Med 1978; 107: 609-15. 14. NIH consensus development conference statement, lowering blood cholesterol to prevent heart disease. Arteriosclerosis 1985; 5 : 404-12. 15. Illingworth RD. Comparative efficiency of once versus twice daily mevinolin in the therapy of familial hypercholesterolemia. Clin Parmacol Ther 1986; 40: 338-43. 16. Lipid Research Clinics Program. The lipid research clinics coronary primary prevention trial results: 1. reduction in incidence of coronary heart disease. JAMA 1984; 251: 351-64. 17. Sigurdsson G. Arfgeng hyperkólesterolemía. Læknablaðið 1980; 66: 103-9. 18. Vega GL, Grundy SM. Treatment of primary moderate hypercholesterolemia with lovastatin (mevinolin) and colestipol. JAMA 1987; 257: 33-8. 19. Bilheimer DW, Grundy SM, Brown MS, Goldstein JL. Mevinolin and colestipol stimulate receptor - medicated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes. Proc Natl Acad Sci-USA 1983; 80: 4124-8. 20. Frick MH et al. Helsinki heart study: Primary prevention trial with gemfibrosil in middle-aged men with dyslipidemia. N Engl J Med 1987; 317: 1237-45. 21. Hunninghake DB, Miller VT, Palmer RH. Therapeutic response to lovastatin in nonfamilial hypercholesterolemia. JAMA 1986; 256: 2829-34. 22. Castelli WP, Garrison RJ, Wilson PWP, Abbott DR, Kaloushin R, Kannel WB. Incidence of ‘ coronary heart disease and lipoprotein cholesterol levels. The Framingham study. JAMA 1986; 256: 2835-8. 23. Hveg JM, Maher MB, Bailey KR et al. Comparison of six pharmacological regimens for hypercholesterolemia. Am J Cardiol 1987; 59: 812-15. 24. Hoeg JM, Brewer HB. 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the treatment of hypercholesterolemia. JAMA 1987; 258: 3532-6. 25. Illingworth DR, Corbin D. The influecne of mevinolin on the adrenal cortical response to corticotropin in heterozygous familial hypercholesterolemia. Proc Natl Acad Sci USA 1985; 82: 6291-4. 26. Blankenhorn DH et al. Benefical effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 1987; 257: 3233-40.

x

Læknablaðið

Beinir tenglar

Ef þú vilt tengja á þennan titil, vinsamlegast notaðu þessa tengla:

Tengja á þennan titil: Læknablaðið
https://timarit.is/publication/986

Tengja á þetta tölublað:

Tengja á þessa síðu:

Tengja á þessa grein:

Vinsamlegast ekki tengja beint á myndir eða PDF skjöl á Tímarit.is þar sem slíkar slóðir geta breyst án fyrirvara. Notið slóðirnar hér fyrir ofan til að tengja á vefinn.